46. Malignant rheumatoid arthritis
4,183 clinical trials,   2,538 drugs   (DrugBank: 401 drugs),   183 drug target genes,   219 drug target pathways

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00825409
(ClinicalTrials.gov)
January 200916/1/2009Safety and Effectiveness Study of Ascension's PyroCarbon Radial Head Compared to Ascension's Metal Radial HeadSafety and Effectiveness Study of Ascension's PyroCarbon Radial Head Compared to Ascension's Metal Radial Head to Treat Arthritis, Fractures of the Radial Head, Relief of Symptoms After Radial Head Resection, or Revision of a Failed Radial Head Implant.Degenerative Arthritis;Post-Traumatic Arthritis;Rheumatoid ArthritisDevice: Carbon Modular Radial Head;Device: Metal Radial HeadAscension Orthopedics, Inc.NULLRecruiting18 Years85 YearsBoth203N/AUnited States
2NCT02405234
(ClinicalTrials.gov)
January 20094/11/2014Ascension PyroCarbon Radial Head StudySafety and Effectiveness Study of Ascension PyroCarbon Radial Head Compared to Ascension Metal Radial HeadDegenerative Arthritis;Radial Head Fracture;Rheumatoid ArthritisDevice: Carbon Modular Radial Head replacement;Device: Metal Radial Head replacementIntegra LifeSciences CorporationNULLTerminated18 Years85 YearsAll78N/AUnited States